IPO

Entero Healthcare Solutions Ltd

Initial public offering of 12,725,244# equity shares of face value of Rs. 10 each ("Equity") of Entero Healthcare Solutions Limited (The "Company" or the "Issuer") for cash at a price of Rs. 1,258 per equity share including a share premium of Rs. 1,248 per equity share (the "Offer Price") aggregating to Rs. 1600.00# crores (the "Offer"). The offer comprises of a fresh issue of 7,955,769# equity shares by the company aggregating to Rs. 1000.00# crores (the "Fresh Issue") and an offer for sale of 4,769,475# equity shares (the "Offered Shares") aggregating to Rs. 600.00# crores (the "Offer for Sale"), comprising of 470,210# equity shares aggregating to Rs. 59.15# crores by Prabhat Agrawal, 313,472# equity shares aggregating to Rs. 39.44# crores by Prem Sethi, 3,815,580# equity shares aggregating to Rs. 480.00# crores by Orbimed Asia iii Mauritius Limited, 4,401# equity shares aggregating to Rs. 0.55# crores by Chethan M.P., 1,320# equity shares aggregating to Rs. 0.17# crores by Deepesh T. Gala, 8,802# equity shares aggregating to Rs. 1.11# crores by Hemant Jose Barros, 4,401# equity shares aggregating to Rs. 0.55# crores by Hemant Jaggi, 2,201# equity shares aggregating to Rs. 0.28# crores by K.R.V.S. Varaprasad, 39,610# equity shares aggregating to Rs. 4.98# crores by K.E. Prakash, 1,320# equity shares aggregating to Rs. 0.17# crores by Lavu Sahadev, 12,103# equity shares aggregating to Rs. 1.52# crores by Manoj K Sanghani, 8,802# equity shares aggregating to Rs. 1.11# crores by Millennium Medicare Private Limited, 2,201# equity shares aggregating to Rs. 0.28# crores by K. Naveen Kumar Gupta, 42,250# equity shares aggregating to Rs. 5.32# crores by Novacare Drug Specialities Private Limited, 15,074# equity shares aggregating to Rs. 1.90# crores by Petros Diamantides, 13,203# equity shares aggregating to Rs. 1.66# crores by Prashanth Ravindrakumar, 1,102# equity shares aggregating to Rs. 0.14# crores by Suraj Prakash Atreja, 1,320# equity shares aggregating to Rs. 0.17# crores by Venkata Ramana Siva Kumar Yanamadala, 12,103# equity shares aggregating to Rs. 1.52# crores by Vikramaditya Ambre (collectively the "Selling Shareholders") (the "Offer for Sale, and together with the fresh issue, the "Offer"). The offer will constitute 29.25%# of the post-offer paid-up equity share capital of the company. The offer included a reservation of 70,237# equity shares, aggregating to Rs. 8.00# crores (constituting 0.16%# of the post-offer paid-up equity share capital), for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer constitute 29.25%# and 29.09%#, respectively, of the post-offer paid-up equity share capital of the company. The company, in consultation with the book running lead managers, offered a discount of 9.46% to the offer price to eligible employees bidding in the employee reservation portion ("Employee Discount"). #Subject to finalisation of basis of allotment The face value of equity shares is Rs. 10 each. The offer price is 125.80 times the face value of the equity shares.
Issue
Opens On Closes On
09-Feb-24 13-Feb-24
Money Payable On
Application Allotment
1258.00 0.00
Minimum Application for shares in Nos : 11 Further Multiples of : 11
Cr Lead Managers to the Issue
Project Cost (.Cr) 951.20 Dam Capital Advisors Ltd
Project Financed through Current Offer (.Cr) 1600.00  
Post Issue Equity Share Capital (.Cr) 43.50
Issue Price () 1258.00
Projects
Repayment/prepayment in full or part of certain borrowings availed by the company and its subsidiaries
Funding the long term working capital requirements
General corporate purposes
Pursuing inorganic growth intiatives through acquisitions
Promoted By
Prabhat Agrawal
Prem Sethi
Orbimed Asia III Mauritius Ltd
Listing At
BSE
NSE
Registrar to the Issue
No Data Available